Atara biotherapeutics to participate in cell therapies in autoimmune panel discussion at the citi 18th annual biopharma conference

Thousand oaks, calif.--(business wire)---- $atra #cart--atara biotherapeutics, inc. (nasdaq: atra), a leader in t-cell immunotherapy, leveraging its novel allogeneic epstein-barr virus (ebv) t-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that pascal touchon, president and chief executive officer, will participate in a cell therapies in autoimmune panel discussion at the citi 18th annual biopharma conference on thursday, september 7, 2023 at.
ATRA Ratings Summary
ATRA Quant Ranking